Biblio

Author Title Type [ Year

]

Filters: Author is Soiffer, Robert J [Clear All Filters]

2018

Roeker, L.E., Kim, H.T., Glotzbecker, B., Nageshwar, P., Nikiforow, S., Koreth, J., Armand, P., Cutler, C., Alyea, E.P., Antin, J.H., et al. (2018). Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.Biol Blood Marrow Transplant.

2016

Wolach, O., Stevenson, K.E., Wadleigh, M., DeAngelo, D.J., Steensma, D.P., Ballen, K.K., Soiffer, R.J., Antin, J.H., Neuberg, D.S., Ho, V.T., et al. (2016). Allogeneic transplantation is not superior to chemotherapy in most patients over 40 years of age with Philadelphia-negative acute lymphoblastic leukemia in first remission.Am J Hematol.

Forcade, E., Kim, H.T., Cutler, C., Wang, K., Alho, A.C., Nikiforow, S., Ho, V.T., Koreth, J., Armand, P., Alyea, E.P., et al. (2016). Circulating T follicular helper cells with increased function during chronic graft-versus-host-disease.Blood.

Deol, A., Sengsayadeth, S., Ahn, K.Woo, Wang, H.-L., Aljurf, M., Antin, J.Harry, Battiwalla, M., Bornhäuser, M., Cahn, J.-Y., Camitta, B., et al. (2016). Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis.Cancer.

Davids, M.S., Kim, H.T., Bachireddy, P., Costello, C., Liguori, R., Savell, A., Lukez, A.P., Avigan, D., Bin Chen, Y.-, McSweeney, P., et al. (2016). Ipilimumab for Patients with Relapse after Allogeneic Transplantation.N Engl J Med375, 143-153.

Herrera, A.F., Kim, H.T., Kong, K.A., Faham, M., Sun, H., Sohani, A.R., Alyea, E.P., Carlton, V.E., Bin Chen, Y.-, Cutler, C.S., et al. (2016). Next-generation sequencing-based detection of circulating tumour DNA After allogeneic stem cell transplantation for lymphoma.Br J Haematol.

McDonald-Hyman, C., Flynn, R., Panoskaltsis-Mortari, A., Peterson, N., MacDonald, K.P.A., Hill, G.R., Luznik, L., Serody, J.S., Murphy, W.J., Maillard, I., et al. (2016). Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5 dependent manner.Blood.

2015

El-Jawahri, A., Li, S., Antin, J.H., Spitzer, T.R., Armand, P.A., Koreth, J., Nikiforow, S., Ballen, K.K., Ho, V.T., Alyea, E.P., et al. (2015). Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in The Modern Years.Biol Blood Marrow Transplant.

2014

Koreth, J., Kim, H.T., Nikiforow, S., Milford, E.L., Armand, P., Cutler, C., Glotzbecker, B., Ho, V.T., Antin, J.H., Soiffer, R.J., et al. (2014). Donor Chimerism Early after Reduced-intensity Conditioning Hematopoietic Stem Cell Transplantation Predicts Relapse and Survival.Biol Blood Marrow Transplant.

Dubovsky, J.A., Flynn, R., Du, J., Harrington, B.K., Zhong, Y., Kaffenberger, B., Yang, C., Towns, W.H., Lehman, A., Johnson, A.J., et al. (2014). Ibrutinib treatment ameliorates murine chronic graft-versus-host disease.J Clin Invest.

Murase, K., Kim, H.T., Bascug, O.R.Gregory, Kawano, Y., Ryan, J., Matsuoka, K.-I., Davids, M.S., Koreth, J., Ho, V.T., Cutler, C., et al. (2014). Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation.Haematologica.

Peixoto, D., Gagne, L.S., Hammond, S.P., Gilmore, E.T., Joyce, A.C., Soiffer, R.J., and Marty, F.M. (2014). Isavuconazole treatment of a patient with disseminated mucormycosis.J Clin Microbiol.

Armand, P., Kim, H.T., Logan, B.R., Wang, Z., Alyea, E.P., Kalaycio, M.E., Maziarz, R.T., Antin, J.H., Soiffer, R.J., Weisdorf, D.J., et al. (2014). Validation and refinement of the disease risk index for allogeneic stem cell transplantation: a study from the CIBMTR.Blood.